非酒精性脂肪肝合并结直肠息肉患者与TyG指数的相关性
Correlation between Non-Alcoholic Fatty Liver Disease with Colorectal Polyps and the Triglyceride-Glucose Index
DOI: 10.12677/acm.2024.1472087, PDF,    科研立项经费支持
作者: 黄继华, 刘界宇, 李泗云, 吉玉屏, 郭萌萌, 张 帆*:云南省第三人民医院消化内科,云南 昆明;刘中建:云南省第一人民医院基础和临床医学研究所,云南 昆明
关键词: 非酒精性脂肪肝结直肠息肉甘油三酯–葡萄糖指数Non-Alcoholic Fatty Liver Disease Colorectal Polyps Triglyceride-Glucose Index
摘要: 目的:分析非酒精性脂肪肝患者中甘油三酯–葡萄糖(TyG)指数作为结直肠息肉一个独立预测指标的有效性。方法:研究910名NAFLD患者,其中包括674例结直肠息肉患者和236例非结直肠息肉患者。采用最小绝对收缩和选择算子(LASSO)回归评估TyG指数与结直肠息肉风险的相关性。采用限制性立方样条(RCS)检验TyG指数与结直肠息肉的线性相关性。构建ROC曲线分析结直肠息肉的TyG指数预测值。结果:LASSO回归分析显示,TyG与结直肠息肉风险显著相关。RCS显示,在整个TyG指数范围内,结直肠息肉风险随TyG指数线性增加。此外,ROC曲线分析表明,TyG水平与传统危险因素相结合,提高了结直肠息肉的预测价值。结论:TyG指数有助于评估非酒精性脂肪肝患者发生结直肠息肉的风险。非酒精性脂肪肝和TyG指数升高的患者发生结直肠息肉的风险更高。因此,在管理NAFLD患者时,应评估TyG指数。
Abstract: Objective: To analyze the efficacy of the triglyceride-glucose (TyG) index as an independent predictive marker for colorectal polyps in patients with non-alcoholic fatty liver disease (NAFLD). Methods: The study involved 910 NAFLD patients, including 674 with colorectal polyps and 236 without. The least absolute shrinkage and selection operator (LASSO) regression was utilized to evaluate the correlation between the TyG index and the risk of colorectal polyps. A restricted cubic spline (RCS) test was employed to examine the linear relationship between the TyG index and colorectal polyps. Receiver operating characteristic (ROC) curve analysis was conducted to assess the predictive value of the TyG index for colorectal polyps. Results: LASSO regression analysis indicated a significant correlation between the TyG index and the risk of colorectal polyps. RCS demonstrated a linear increase in the risk of colorectal polyps across the entire range of the TyG index. Furthermore, ROC curve analysis showed that combining TyG levels with traditional risk factors enhanced the predictive value for colorectal polyps. Conclusion: The TyG index aids in assessing the risk of colorectal polyps in patients with non-alcoholic fatty liver disease. Patients with NAFLD and elevated TyG indices have a higher risk of developing colorectal polyps. Therefore, the TyG index should be evaluated in the management of NAFLD patients.
文章引用:黄继华, 刘界宇, 李泗云, 吉玉屏, 郭萌萌, 刘中建, 张帆. 非酒精性脂肪肝合并结直肠息肉患者与TyG指数的相关性[J]. 临床医学进展, 2024, 14(7): 841-853. https://doi.org/10.12677/acm.2024.1472087

参考文献

[1] Dekker, E., Tanis, P.J., Vleugels, J.L.A., Kasi, P.M. and Wallace, M.B. (2019) Colorectal Cancer. The Lancet, 394, 1467-1480. [Google Scholar] [CrossRef] [PubMed]
[2] Ng, L., Sin, R.W., Cheung, D.H., Leung, W., Man, A.T., Lo, O.S., et al. (2023) Serum Microrna Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients. International Journal of Molecular Sciences, 24, Article 9084. [Google Scholar] [CrossRef] [PubMed]
[3] Caputo, V., Tarantino, G., Santini, S.J., Fracassi, G. and Balsano, C. (2023) The Role of Epigenetic Control of Mitochondrial (Dys)Function in MASLD Onset and Progression. Nutrients, 15, Article 4757. [Google Scholar] [CrossRef] [PubMed]
[4] Mantovani, A., Dauriz, M., Byrne, C.D., Lonardo, A., Zoppini, G., Bonora, E., et al. (2018) Association between Nonalcoholic Fatty Liver Disease and Colorectal Tumours in Asymptomatic Adults Undergoing Screening Colonoscopy: A Systematic Review and Meta-Analysis. Metabolism, 87, 1-12. [Google Scholar] [CrossRef] [PubMed]
[5] Li, H., Wang, J., Liu, H., Lan, T., Xu, L., Wang, G., et al. (2020) Existence of Intratumoral Tertiary Lymphoid Structures Is Associated with Immune Cells Infiltration and Predicts Better Prognosis in Early-Stage Hepatocellular Carcinoma. Aging, 12, 3451-3472. [Google Scholar] [CrossRef] [PubMed]
[6] 陈旋. 非酒精性脂肪性肝病病人血清长链非编码NTF3-5水平与胰岛素抵抗的关系[J]. 安徽医药, 2024, 28(2): 285-289.
[7] Chen, Q., Zhou, X., Sun, Y., Fang, D., Zhao, Q., Huang, J., et al. (2017) Sex-Influenced Association of Non-Alcoholic Fatty Liver Disease with Colorectal Adenomatous and Hyperplastic Polyps. World Journal of Gastroenterology, 23, 5206-5215. [Google Scholar] [CrossRef] [PubMed]
[8] Son, D., Lee, H.S., Lee, Y., Lee, J. and Han, J. (2022) Comparison of Triglyceride-Glucose Index and HOMA-IR for Predicting Prevalence and Incidence of Metabolic Syndrome. Nutrition, Metabolism and Cardiovascular Diseases, 32, 596-604. [Google Scholar] [CrossRef] [PubMed]
[9] Li, X., Zhan, F., Peng, T., Xia, Z. and Li, J. (2023) Association between the Triglyceride-Glucose Index and Non-Alcoholic Fatty Liver Disease in Patients with Atrial Fibrillation. European Journal of Medical Research, 28, Article No. 355. [Google Scholar] [CrossRef] [PubMed]
[10] Liu, T., Zhang, Q., Wang, Y., Ma, X., Zhang, Q., Song, M., et al. (2022) Association between the TyG Index and TG/HDL-C Ratio as Insulin Resistance Markers and the Risk of Colorectal Cancer. BMC Cancer, 22, Article No. 1007. [Google Scholar] [CrossRef] [PubMed]
[11] Wang, L., Li, Y. and Dong, L. (2024) Transient Elastography with Controlled Attenuation Parameter for the Diagnosis of Colorectal Polyps in Patients with Nonalcoholic Fatty Liver Disease. World Journal of Clinical Cases, 12, 2050-2055. [Google Scholar] [CrossRef] [PubMed]
[12] Liu, H., Chen, J., Qin, Q., Yan, S., Wang, Y., Li, J., et al. (2024) Association between TyG Index Trajectory and New-Onset Lean NAFLD: A Longitudinal Study. Frontiers in Endocrinology, 15, Article 1321922. [Google Scholar] [CrossRef] [PubMed]
[13] 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版) [J]. 临床肝胆病杂志, 2018, 34(5): 947-957.
[14] Sangro, P., de la Torre Aláez, M., Sangro, B. and D’Avola, D. (2023) Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update of the Recent Advances in Pharmacological Treatment. Journal of Physiology and Biochemistry, 79, 869-879. [Google Scholar] [CrossRef] [PubMed]
[15] Rong, L., Zou, J., Ran, W., Qi, X., Chen, Y., Cui, H., et al. (2023) Advancements in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD). Frontiers in Endocrinology, 13, Article 1087260. [Google Scholar] [CrossRef] [PubMed]
[16] Xu, W.M., Zhang, H.F., Feng, Y.H., et al. (2024) Genetically Predicted Fatty Liver Disease and Risk of Psychiatric Disorders: A Mendelian Randomization Study. World Journal of Clinical Cases, 12, 2359-2369.
[17] Chen, J., Bian, D., Zang, S., Yang, Z., Tian, G., Luo, Y., et al. (2019) The Association between Nonalcoholic Fatty Liver Disease and Risk of Colorectal Adenoma and Cancer Incident and Recurrence: A Meta-Analysis of Observational Studies. Expert Review of Gastroenterology & Hepatology, 13, 385-395. [Google Scholar] [CrossRef] [PubMed]
[18] Kim, M.C., Park, J.G., Jang, B.I., Lee, H.J. and Lee, W.K. (2019) Liver Fibrosis Is Associated with Risk for Colorectal Adenoma in Patients with Nonalcoholic Fatty Liver Disease. Medicine, 98, e14139. [Google Scholar] [CrossRef] [PubMed]
[19] Wang, J., Yan, S., Cui, Y., Chen, F., Piao, M. and Cui, W. (2022) The Diagnostic and Prognostic Value of the Triglyceride-Glucose Index in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): A Systematic Review and Meta-Analysis. Nutrients, 14, Article 4969. [Google Scholar] [CrossRef] [PubMed]
[20] Li, H.F., Miao, X. and Li, Y. (2023) The Triglyceride Glucose (TyG) Index as a Sensible Marker for Identifying Insulin Resistance and Predicting Diabetic Kidney Disease. Medical Science Monitor, 29, e939482.
[21] Li, J., Chen, J., Liu, H., Yan, S., Wang, Y., Xing, M., et al. (2024) Association of the Triglyceride-Glucose Index with the Occurrence and Recurrence of Colorectal Adenomas: A Retrospective Study from China. BMC Public Health, 24, Article No. 579. [Google Scholar] [CrossRef] [PubMed]
[22] Okamura, T., Hashimoto, Y., Hamaguchi, M., Obora, A., Kojima, T. and Fukui, M. (2020) Triglyceride-Glucose Index (TyG Index) Is a Predictor of Incident Colorectal Cancer: A Population-Based Longitudinal Study. BMC Endocrine Disorders, 20, Article No. 113. [Google Scholar] [CrossRef] [PubMed]
[23] Li, W., Liu, T., Qian, L., Wang, Y., Ma, X., Cao, L., et al. (2022) Insulin Resistance and Inflammation Mediate the Association of Abdominal Obesity with Colorectal Cancer Risk. Frontiers in Endocrinology, 13, Article 983160. [Google Scholar] [CrossRef] [PubMed]
[24] Ning, Y., Wang, L. and Giovannucci, E.L. (2009) A Quantitative Analysis of Body Mass Index and Colorectal Cancer: Findings from 56 Observational Studies. Obesity Reviews, 11, 19-30. [Google Scholar] [CrossRef] [PubMed]
[25] Nguyen, S.P., Bent, S., Chen, Y. and Terdiman, J.P. (2009) Gender as a Risk Factor for Advanced Neoplasia and Colorectal Cancer: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 7, 676-681.E3. [Google Scholar] [CrossRef] [PubMed]
[26] Kim, S. (2015) Sex-and Gender-Specific Disparities in Colorectal Cancer Risk. World Journal of Gastroenterology, 21, 5167-5175. [Google Scholar] [CrossRef] [PubMed]
[27] Lieberman, D.A., Williams, J.L., Holub, J.L., Morris, C.D., Logan, J.R., Eisen, G.M., et al. (2014) Race, Ethnicity, and Sex Affect Risk for Polyps > 9 mm in Average-Risk Individuals. Gastroenterology, 147, 351-358. [Google Scholar] [CrossRef] [PubMed]
[28] Kaneko, H., Yano, Y., Itoh, H., Morita, K., Kiriyama, H., Kamon, T., et al. (2021) Untreated Hypertension and Subsequent Incidence of Colorectal Cancer: Analysis of a Nationwide Epidemiological Database. Journal of the American Heart Association, 10, e022479. [Google Scholar] [CrossRef] [PubMed]